ETFs Holding KBIO »    KBIO Historical Stock Prices »
KBIO News Video: Wed, Nov 25, 2015, 1:23 PM — Wednesday Sector Leaders: Biotechnology, Apparel Stores

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Kalobios Pharmaceuticals is a biopharmaceutical company focused on the development of monoclonal antibody therapeutics. Using Co.'s Humaneered® antibody technology, Co. has produced a portfolio of antibodies to treat medical conditions with a primary clinical focus on respiratory diseases and cancer. Co. has developed three monoclonal antibodies to the clinical development stage: KB004, which is a Humaneered® anti-EphA3 monoclonal antibody; KB003, which is a Humaneered® anti-granulocyte macrophage colony-stimulating factor monoclonal antibody; and KB001-A, which is a Humaneered® developed for the prevention and treatment of Pseudomonas aeruginosa infections. Self directed investors in KaloBios Pharmaceuticals Inc will be interested in keeping up with all KaloBios Pharmaceuticals Inc news they can find, both KBIO news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on KBIO. At RediNews, we simplify this task by presenting both KBIO news releases originating from KaloBios Pharmaceuticals Inc itself, and KBIO news from a variety of media outlets. Visitors can browse this news online and through our KBIO RSS news feed.


KBIO News — Articles, Videos, & Press Releases

KBIO is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:


RediNews would like to be your web content provider of choice for news feeds by stock ticker symbol, or by market sector. An ideal complement to other financial content like stock quotes and charts, our news gives your users what they want — to see what is being published about the stocks they own, and what the companies themselves are publishing. Simply navigate to any RediNews news page by specific ticker symbol, then click the RSS icon for any news page to reach the associated RSS feed (the icon will look like this): . There is no charge to use our feeds, they are available to you for free.

KBIO News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.